MindMaze Therapeutics (SIX: MMTX) has announced the signing of a definitive channel partnership agreement with closely held Vibra Healthcare to introduce MindMaze’s FDA-cleared digital neurotherapeutics platform to U.S. health systems.
Under the agreement, Vibra will leverage its U.S. relationships and operational credibility to connect MindMaze with providers investing in advanced neurorehabilitation capabilities.
In a statement, Zach Henderson, CEO of MindMaze, commented, “This next phase of our collaboration with Vibra is a significant step in MindMaze Therapeutics’ U.S. commercial expansion. Vibra has successfully implemented our platform across multiple care settings, and together we have demonstrated the results and built the operational playbook. We are now positioned to replicate that proven model with health systems across the country and further build our U.S. footprint.”
